rxstat › Classes › Gonadotrophins And Other Ovulation Stimulants

Gonadotrophins And Other Ovulation Stimulants: shortage status in Canada

1 of the 6 gonadotrophins and other ovulation stimulants rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Choriogonadotropin Alfa (Ovidrel) Partial shortage 1 of 2 reported products affected · est. return Sep 30, 2026 Chorionic Gonadotropin (Pregnyl) No current shortage Clomiphene (Serophene) Discontinued 0 of 2 reported products affected Follitropin Alfa (Gonal-F) No current shortage Lutropin Alfa (Luveris) No current shortage Urofollitropin For Injection (Bravelle) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.